The high price of anticancer drugs: origins, implications, barriers, solutions
V Prasad, K De Jesús, S Mailankody - Nature reviews Clinical oncology, 2017 - nature.com
Globally, annual spending on anticancer drugs is around US $100 billion, and is predicted
to rise to $150 billion by 2020. In the USA, a novel anticancer drug routinely costs more than …
to rise to $150 billion by 2020. In the USA, a novel anticancer drug routinely costs more than …
Determinants of market exclusivity for prescription drugs in the United States
The high prices of brand-name prescription drugs are a growing source of controversy in the
United States. Manufacturers of brand-name drugs can command high prices because they …
United States. Manufacturers of brand-name drugs can command high prices because they …
[HTML][HTML] The state of cancer care in America, 2016: a report by the American Society of Clinical Oncology
American Society of Clinical Oncology - Journal of oncology …, 2016 - ncbi.nlm.nih.gov
Cancer care in the United States remained a mixed picture in 2015. Declining mortality
rates, growing numbers of survivors, and exciting progress in treatment were set against the …
rates, growing numbers of survivors, and exciting progress in treatment were set against the …
Financialized corporations in a national innovation system: the US pharmaceutical industry
Ö Tulum, W Lazonick - International Journal of Political Economy, 2018 - Taylor & Francis
There are widespread claims that a productivity crisis afflicts the US pharmaceutical industry
despite the fact that the US institutional environment provides unique advantages for drug …
despite the fact that the US institutional environment provides unique advantages for drug …
[HTML][HTML] Payers' experiences with confidential pharmaceutical price discounts: a survey of public and statutory health systems in North America, Europe, and …
Institutional payers for pharmaceuticals worldwide appear to be increasingly negotiating
confidential discounts off of the official list price of pharmaceuticals purchased in the …
confidential discounts off of the official list price of pharmaceuticals purchased in the …
Changes in retail prices of prescription dermatologic drugs from 2009 to 2015
ME Rosenberg, SP Rosenberg - JAMA dermatology, 2016 - jamanetwork.com
Importance Physicians from many specialties as well as primary care prescribe dermatologic
medications; as insurance formularies become increasingly restrictive and more patients are …
medications; as insurance formularies become increasingly restrictive and more patients are …
[图书][B] Fiscal Therapy: Curing America's Debt Addiction and Investing in the Future
WG Gale - 2019 - books.google.com
Keeping the economy strong will require addressing two distinct but related problems.
Steadily rising federal debt makes it harder to grow our economy, boost our living standards …
Steadily rising federal debt makes it harder to grow our economy, boost our living standards …
[PDF][PDF] Combating corruption in the pharmaceutical arena
Corruption in healthcare generally and specifically in the pharmaceutical arena has recently
been highlighted in reports by Transparency International. This article focuses on four areas …
been highlighted in reports by Transparency International. This article focuses on four areas …
Stemming the escalating cost of prescription drugs: a position paper of the American College of Physicians
H Daniel… - Annals of Internal …, 2016 - acpjournals.org
This American College of Physicians position paper, initiated and written by its Health and
Public Policy Committee and approved by the Board of Regents on 16 February 2016 …
Public Policy Committee and approved by the Board of Regents on 16 February 2016 …
The real meaning of “Managed Care”: Adaptive accumulation and US Health care
R Loeppky - International Journal of Health Services, 2019 - journals.sagepub.com
The boundaries of what constitutes “sufficient” health have always been open and, as such,
health care has proven to be an opportune area for profit growth. In the United States, the …
health care has proven to be an opportune area for profit growth. In the United States, the …